IT
Healthcare & Life Sciences

IMMvention Therapeutix

IMMvention Therapeutix is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.

Activeseries-a
series-a
Stage
1
Investors

About IMMvention Therapeutix

IMMvention Therapeutix is a startup based in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

IMMvention Therapeutix develops small-molecule pan-inflammasome inhibitors targeting inflammatory responses to improve treatments for sickle cell disease and other conditions such as neuroinflammatory, renal, and metabolic diseases.

Explore IMMvention Therapeutix's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States